Par Drugs and Chemicals Limited — Updates, 27-09-2025: General Updates
27-09-2025 | 02:43 pm
27-09-2025 | 02:43 pm
PAR Drugs & Chemicals saw revenue rise to ₹103.12 Cr from ₹95.88 Cr. However, increased expenses led to PBT dropping to ₹17.92 Cr (from ₹19.52 Cr) and net profit to ₹13.36 Cr (from ₹14.50 Cr), showing margin moderation. A strategic transition was also discussed.
No comments yet. Be the first to comment!
